Sinsin Pharmaceutical Co. Ltd (002800) — Free Cash Flow Generation Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of ₩3.83 Billion represents 1% of operating cash flow (₩4.70 Billion). See working capital to net assets of Sinsin Pharmaceutical Co. Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Explore Sinsin Pharmaceutical Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year Free Cash Flow Generation Index for Sinsin Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see market value of Sinsin Pharmaceutical Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | ₩4.43 Billion | ₩5.94 Billion | ₩1.51 Billion | ▲ +366.9% |
| 2023 | -0.28x | ₩-1.10 Billion | ₩3.93 Billion | ₩5.03 Billion | ▼ -134.5% |
| 2022 | 0.81x | ₩4.42 Billion | ₩5.46 Billion | ₩907.13 Million | ▲ +100.7% |
| 2021 | -114.70x | ₩-2.66 Billion | ₩23.18 Million | ₩2.68 Billion | ▼ -1979.4% |
| 2020 | -5.52x | ₩-10.29 Billion | ₩1.87 Billion | ₩11.97 Billion | ▼ -116.3% |
| 2018 | 33.86x | ₩26.21 Billion | ₩774.24 Million | ₩25.44 Billion | ▲ +1800.2% |
| 2017 | 1.78x | ₩8.14 Billion | ₩4.57 Billion | ₩3.57 Billion | ▼ -51.3% |
| 2016 | 3.66x | ₩10.22 Billion | ₩2.79 Billion | ₩7.43 Billion | ▲ +83.2% |
| 2015 | 2.00x | ₩10.46 Billion | ₩5.24 Billion | ₩5.22 Billion | — |